TY  - CHAP
M1  - Book, Section
TI  - The Vascular Biology and Clinical Efficacy of Drug-Eluting Stents for the Treatment of Peripheral Arterial Disease
A1  - Dieter, Robert S.
A1  - Clavijo, Leonardo
A1  - Stevens, Scott L.
A1  - Laird, John R.
A2  - Dieter, Robert S.
A2  - Dieter, Raymond A.
A2  - Dieter, Raymond A.
PY  - 2009
T2  - Peripheral Arterial Disease
AB  - Nearly  10%  of  the  population  older  than  65  years  has  atherosclerotic  lower  extremity  peripheral  arterial  disease.  Older  patients  and  those  with  risk  factors  may  have  up  to  a  25%  incidence  of  lower  extremity  peripheral  arterial  disease.1  Percutaneous  vascular  interventions  are  rapidly  emerging  as  a  less  invasive  therapy  for  symptomatic  lower  extremity  occlusive  arterial  disease.2,3,4  Despite  recent  advances,  restenosis  remains  a  significant  problem  with  catheter-based  revascularization.  By  delivering  high  local  doses,  drug-eluting  stents  have  the  potential  to  overcome  the  limitations  of  restenosis  and  advance  stent-based  therapies  for  lower  extremity  peripheral  arterial  disease  (Table  39-1).  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/18
UR  - accesscardiology.mhmedical.com/content.aspx?aid=1127169011
ER  -